How UiPath Stock Gained 60%
UiPath (PATH)’s stock skyrocketed 61%, fueled less by a slight revenue lift and more by a surge in investor optimism. Strong quarterly earnings, AI automation excitement, analyst buzz, and even the CEO’s share sale set the stage for this dramatic move. Let’s unpack how these factors converged next.
Below is an analytical breakdown of stock movement into key contributing metrics.
| 9052025 | 12042025 | Change | |
|---|---|---|---|
| Stock Price ($) | 11.5 | 18.5 | 60.8% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 1,451.2 | 1,496.7 | 3.1% |
| P/S Multiple | 4.3 | 6.6 | 52.5% |
| Shares Outstanding (Mil) | 548.5 | 536.2 | 2.2% |
| Cumulative Contribution | 60.8% |
So what is happening here? The stock soared 61%, driven by a modest 3.1% revenue boost and a hefty 52% jump in its P/E multiple. Let’s dive into the events behind these moves next.
Here Is Why UiPath Stock Moved
- Strong Q2 Earnings: Exceeded EPS & revenue forecasts for Q2 FY26. Revenue up 14%, ARR up 11%. Raised FY guidance.
- AI Automation Focus: Shift to agentic automation; partnerships with OpenAI, Snowflake, Google Gemini announced in Oct.
- CEO Share Sale: CEO Daniel Dines sold nearly 30M Class A shares in October, causing a stock decline.
- Analyst Sentiment: Analysts issued varied price targets; some upgrades occurred (e.g., UBS to Neutral in Oct).
- Beat Q3 Earnings: Reported strong Q3 FY26 earnings on Dec 3, beating EPS & revenue. First GAAP profitable Q3.
Our Current Assesment Of PATH Stock
Opinion: We currently find PATH stock fairly priced. Why so? Have a look at the full story. Read Buy or Sell PATH Stock to see what drives our current opinion.
Risk: To get a real sense of risk, check how much PATH fell in tough times. During the inflation shock, it dropped nearly 88% from peak to bottom. That’s a huge hit, even with all the positive factors around it. It shows that no matter how strong a stock looks, severe market stress can still hammer its price hard. The numbers remind us that risk is always there, especially when panic sets in.
PATH stock may have seen strong gains recently, but investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.